Equities

Satudora Holdings Co Ltd

3544:TYO

Satudora Holdings Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)864.00
  • Today's Change-38.00 / -4.21%
  • Shares traded147.90k
  • 1 Year change+12.50%
  • Beta0.1798
Data delayed at least 20 minutes, as of Jun 07 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SATUDORA HOLDINGS CO.,LTD. is a Japan-based company mainly engaged in the management and operation of group companies as well as providing related business. The Company operates health and beauty related products retail business through its subsidiary. It focuses on the retail of pharmaceuticals and cosmetics, as well as the retail of daily necessities and food.

  • Revenue in JPY (TTM)94.04bn
  • Net income in JPY359.00m
  • Incorporated2016
  • Employees1.11k
  • Location
    Satudora Holdings Co Ltd4-1-20, Kita Hachijo Higashi, Higashi-kuSAPPORO-SHI 060-0908JapanJPN
  • Phone+81 117885166
  • Fax+81 117886621
  • Websitehttps://satudora-hd.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sapporo Clinical Laboratory Inc19.68bn380.16m4.22bn938.008.760.30454.690.2142114.16114.165,910.353,283.711.1925.216.74--2.194.662.785.9729.9531.641.843.582.15275.800.164310.36-2.212.89-33.14-6.1912.5618.13
Sophia Holdings Co Ltd9.03bn-100.89m4.49bn215.00--1.4314.450.4974-22.89-22.892,981.09701.281.1811.297.24---1.322.93-2.195.0937.3935.07-1.122.321.4312.750.44450.00-4.1414.77-577.93---12.58--
Pharmarise Holdings Corp53.97bn302.00m7.65bn1.56k23.760.90545.150.141726.6826.684,651.75700.242.1914.0890.6434,709,970.001.281.482.042.4415.8915.110.58550.69420.966536.970.570536.130.8177-0.9458-25.50--6.000.00
Medical Ikkou Group Co Ltd39.90bn1.04bn10.74bn1.43k9.540.7495.760.2692276.70276.7010,618.433,523.261.3523.727.2227,883,290.003.663.115.394.5211.4110.522.712.551.44--0.409618.2417.715.0336.897.88-21.672.38
J Frontier Co Ltd17.01bn-1.71bn12.24bn255.00--4.27--0.7195-360.79-360.793,528.98558.332.076.999.2566,696,210.00-20.89---35.65--46.62---10.10--0.9656-77.390.5128--41.83---574.36------
Satudora Holdings Co Ltd94.04bn359.00m12.26bn1.11k33.121.317.270.130426.0026.006,807.01658.512.166.4735.7884,950,320.000.84680.68451.651.2624.1224.300.39240.30450.43488.160.652657.985.522.19-72.47-10.203.351.39
Hyuga Primary Care Co Ltd8.29bn441.03m12.96bn442.0030.197.7320.551.5659.2659.261,110.52231.461.7934.906.25--9.52--14.71--22.71--5.32--1.1291.550.6301--24.46--15.19------
Medical System Network Co Ltd115.36bn1.86bn18.97bn3.62k10.031.194.700.164461.7161.713,836.48519.081.7212.5030.16--2.792.194.173.3541.5440.831.621.330.656313.490.657223.025.303.2715.5332.12-7.853.71
Nihon Chouzai Co Ltd340.31bn2.55bn43.13bn5.69k16.280.71223.710.126785.3485.3411,375.311,950.411.797.6215.53--1.342.272.343.9416.8217.260.75021.400.623925.750.484917.878.616.73-42.73-7.6012.040.00
Yakuodo Holdings Co Ltd142.24bn3.83bn55.21bn978.0014.331.658.310.3882195.20195.207,259.051,700.132.054.8587.88145,440,700.005.525.548.438.6721.5722.402.692.720.3559168.030.289814.3510.449.1518.025.37-15.284.36
Qol Holdings Co Ltd180.05bn4.88bn58.20bn5.75k11.411.067.610.3232131.08131.084,837.031,414.421.6430.0010.64--4.444.706.767.4512.9113.292.712.831.22--0.374522.795.894.46-13.724.547.041.39
Data as of Jun 07 2024. Currency figures normalised to Satudora Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

1.72%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 30 Apr 202491.70k0.64%
Daiwa Asset Management Co. Ltd.as of 30 Apr 202448.30k0.34%
Nikko Asset Management Co., Ltd.as of 10 May 202444.30k0.31%
Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 202419.50k0.14%
BlackRock Japan Co. Ltd.as of 09 May 202414.80k0.10%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 19 Feb 20248.80k0.06%
Asset Management One Co., Ltd.as of 09 May 20246.00k0.04%
Dimensional Fund Advisors LPas of 31 Jan 20245.70k0.04%
Dimensional Fund Advisors Ltd.as of 30 Apr 20242.70k0.02%
Amundi Asset Management SA (Investment Management)as of 08 May 20242.54k0.02%
More ▼
Data from 31 Mar 2024 - 06 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.